Your browser doesn't support javascript.
loading
Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
Goff, Peter H; Hayashi, Tomoko; Martínez-Gil, Luis; Corr, Maripat; Crain, Brian; Yao, Shiyin; Cottam, Howard B; Chan, Michael; Ramos, Irene; Eggink, Dirk; Heshmati, Mitra; Krammer, Florian; Messer, Karen; Pu, Minya; Fernandez-Sesma, Ana; Palese, Peter; Carson, Dennis A.
Affiliation
  • Goff PH; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Hayashi T; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Martínez-Gil L; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Corr M; Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Crain B; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Yao S; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Cottam HB; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Chan M; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Ramos I; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Eggink D; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Heshmati M; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Messer K; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Pu M; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA.
  • Fernandez-Sesma A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Palese P; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA peter.palese@mssm.edu dcarson@ucsd.edu.
  • Carson DA; UCSD Moores Cancer Center, University of California, San Diego, La Jolla, California, USA peter.palese@mssm.edu dcarson@ucsd.edu.
J Virol ; 89(6): 3221-35, 2015 Mar.
Article in En | MEDLINE | ID: mdl-25568203
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Adjuvants, Immunologic / Toll-Like Receptor 4 / Toll-Like Receptor 7 / Influenza, Human / Influenza A Virus, H1N1 Subtype / Cross Protection Limits: Animals / Humans Language: En Journal: J Virol Year: 2015 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Adjuvants, Immunologic / Toll-Like Receptor 4 / Toll-Like Receptor 7 / Influenza, Human / Influenza A Virus, H1N1 Subtype / Cross Protection Limits: Animals / Humans Language: En Journal: J Virol Year: 2015 Type: Article Affiliation country: United States